Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Drug guidance

Maribavir for treating refractory or drug-intolerant cytomegalovirus infection after transplant

Condition

Infections

1 July 2026

-

Published on 01 Jul 2026
Last Updated on 01 Jul 2026

Guidance Recommendations

The Ministry of Health’s Drug Advisory Committee has recommended:

  • Maribavir 200 mg tablet for treating post-transplant cytomegalovirus infection or disease in adults who are refractory (with or without genotypic resistance) or intolerant to prior antiviral therapy.

Funding status

Maribavir 200 mg tablet is recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indication from 1 September 2026.

Maribavir should be used in line with the additional clinical criteria listed in the Annex.

Guidance_Maribavir for treating refractory or drug-intolerant cytomegalovirus infection after transplant (1 Jul 2026) [PDF, 187.22 KB]

Back to top